A platelet-aggregating and hypotensive phospholipid isolated from bovine brain

Area of Science:

• Lipid biochemistry
• Pharmacology

Background:

• Platelet aggregation and hypotension are critical physiological processes.
• Known active lipids play diverse roles in these processes.
• Bovine brain is a source of bioactive lipids.

Purpose of the Study:

• To isolate and characterize a novel phospholipid from bovine brain.
• To investigate its effects on platelet aggregation and blood pressure.
• To compare its activity with known lipids and platelet-activating factor.

Main Methods:

• Isolation of a phospholipid from bovine brain.
• Assay of platelet aggregation in rabbit heparinized platelet-rich plasma.
• Measurement of blood pressure.
• Chemical modification of the isolated phospholipid using diazomethane treatment.
• Inhibition studies using CV-3988 and platelet-activating factor.

Main Results:

• A novel phospholipid was isolated, exhibiting potent platelet aggregation and weak hypotension.
• The platelet aggregation effect had a threshold concentration of approximately 0.2 nmol/mL (as phosphorus) and was inhibited by CV-3988.
• Diazomethane treatment converted the phospholipid into a lipid that caused short-term hypotension but inhibited platelet aggregation, including that induced by platelet-activating factor.

Conclusions:

• A unique phospholipid from bovine brain influences platelet function and blood pressure.
• This phospholipid and its derivative demonstrate distinct pharmacological activities.
• The findings suggest novel mechanisms in lipid-mediated physiological regulation.